ArticleCancer science2015

Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing state.

Miki Tongu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.